Article Information
History
- October 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Roxane Dilcher, MSc1,
- Charles B. Malpas, PhD1,2,3,4,
- William T. O’Brien, PhD1,
- Stuart J. McDonald, PhD1,6,
- Craig Despott, Bsc7,
- Kelly Bertram, MD1,9,
- Matthew P. Pase, PhD5,6,
- Meng Law, MD1,8,
- Terence J. O’Brien, MD1,2,3,9 and
- Lucy Vivash, PhD1,2,3,9,*
- 1Department of Neurosciences, School of Translational Medicine, Monash University, Melbourne, VIC Australia
- 2Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC Australia
- 3Department of Neurology, Royal Melbourne Hospital, Melbourne, VIC, Australia
- 4Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, VIC Australia
- 5School of Psychological Sciences, Turner Institute for Brain and Mental Health, Monash University, Clayton, VIC, Australia
- 6Harvard T.H. Chan School of Public Health, Boston, MA, USA
- 7Department of Nuclear Medicine, Alfred Health, Melbourne, VIC 3004, Australia
- 8Department of Radiology, Alfred Health, Melbourne, VIC 3004, Australia
- 9Department of Neurology, Alfred Hospital, Melbourne, VIC Australia
- ↵*Correspondance: Dr Lucy Vivash lucy.vivash{at}monash.edu Senior Research Fellow Department of Neuroscience, Monash University 99 Commercial Rd, Melbourne VIC 3004
Posted October 15, 2024.
Linking PI-2620 tau-PET, fluid biomarkers, MRI, and cognition to advance diagnostics for progressive supranuclear palsy
